Trevi Therapeutics公司近日宣布，其研究成果已获选在美国胸科学会（ATS）2026年国际会议上进行展示。此次入选包括一场重磅的口头学术报告以及多篇壁报展示，彰显了该公司在呼吸疾病治疗领域的科研实力。
该会议是全球呼吸病学领域的权威学术盛会，汇集了来自世界各地的顶尖专家学者。Trevi Therapeutics此次多项研究成果同时获得展示机会，反映了行业对其创新疗法的高度关注。
Trevi Therapeutics公司近日宣布，其研究成果已获选在美国胸科学会（ATS）2026年国际会议上进行展示。此次入选包括一场重磅的口头学术报告以及多篇壁报展示，彰显了该公司在呼吸疾病治疗领域的科研实力。
该会议是全球呼吸病学领域的权威学术盛会，汇集了来自世界各地的顶尖专家学者。Trevi Therapeutics此次多项研究成果同时获得展示机会，反映了行业对其创新疗法的高度关注。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.